Author: Ed Lotterman

Fed’s interest in rates is all about bonds

After the Federal Open Market Committee met Tuesday, it issued this statement: “The Federal Open Market Committee decided today to keep its target for the federal funds rate at 1 percent.” That is a matter-of-fact statement that most people understand.…

Shielding drugs, rock ‘n’ roll

Two unrelated public controversies — drug costs and music copying — highlight an important economic lesson. Society benefits when governments grant property rights in intellectual property through patents and copyrights. But the benefits can be costly. Patents and copyrights help…

Like farmers, small businesses need assistance

The changes last week at Minnesota Technology Inc. highlight an interesting paradox in public policy. Historically, we have devoted substantial resources to technical and management assistance for farmers. But similar help for small businesses continues to get short shrift. Are…

Drug benefit is close to “bilateral monopoly”

The as-yet unfinished legislation establishing a prescription drug benefit as part of Medicare will set an interesting milestone. When enacted, the United States will face a situation of effective “bilateral monopoly” in the production and sale of many pharmaceuticals. It…

A lesson in “rent seeking”

Recent stories in this newspaper describing the financial ties involving Gov. Tim Pawlenty, State Auditor Pat Awada and Metropolitan Airport Commissioner Victoria Grunseth with a telecom firm accused of fraudulent practices in several states illustrate the subtleties of a phenomenon…